Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Isabel Hatami

Project Manager

I started my career as a Scientist for Oxford Nanopore Technologies, after completing a MChem at the University of Surrey. Moving through the company from a Research Scientist working on a then prototype DNA sequencer, now known as MinION, to a Process Transfer Scientist between Development and Production focusing on the wet chemistry for sequencing chips.

Next, after finishing my MSc in Applied Human Nutrition at Oxford Brookes University I continued my career in a food-tech company called Spoon Guru. Here my focus was on food product packaging looking at legislation, nutritional information and allergens in the UK and across the world including North America, Australia and Asia. As Company Nutritionist and QA Manager I ensured all regulations were adhered too and the quality of our analysis was accurate.

In 2020, I joined Oxford Brookes University as the Centre Manager of the Centre for Nutrition and Health, running all commercial funded research carried out by the Nutrition department. Here I managed the research team and research studies, from inception to dissemination. This included on site and remote studies, from standard Glycaemic Index testing to large scale nutritional interventions on a range of outcomes from glycaemic behaviour and satiety to blood pressure.

In November 2023, I joined Prof. Laurent Servais' research group as Project Manager and the the newborn screening (NBS) studies which currently focus on NBS for SMA (Spinal Muscular Atrophy) across the Thames Valley and Wessex regions. This feasibility study has been implemented to understand the barriers to NBS for SMA in the UK with the aim for eventually SMA to be incorporated as part of the standard newborn screening.